Defence, Security, Energy, Utilities, Finance, Pharmaceuticals
Home > Pharmaceuticals > UK

Asthma & COPD

2nd April to 3rd April 2014, London, United Kingdom

Overview

Open/Close

SMi proudly present their 10th annual Asthma and COPD conference taking place in Central London on Wednesday 2nd and Thursday 3rd April, 2014. 

This year’s event will focus on the cutting edge concepts driving the developments of asthma and COPD forward.


There is a growing demand for the next generation of inhaled combination products and novel therapeutics. This conference will enable delegates to gain valuable insight into the latest ground-breaking advances in the respiratory drug market. It will focus on the challenges and strategies to enhance patient outcomes, providing extensive knowledge from the key leading industry and academic experts.

The agenda will focuss on the treatment for exacerbations, clinical trial design and strategies for method enhancement, biomarkers and the utilisation of devices for Asthma and COPD. Key focus will be put on the anti-inflammatory developments in addition to the efficacy and toxicological issues relating to combination products.

Insight will be given on the current regulatory requirements and enable delegates to stay up to date with the guidelines.

A new session for 2014 will look at Cystic fibrosis, how does this relate to the developments within asthma and COPD?

 


 

Benefits of Attending

Open/Close

Featured Speakers

Open/Close

Who Should Attend

Open/Close